Scottish Parkinson’s support group awarded £60,000 from Big Lottery Fund

News

Author: Parkinson's Life editorsPublished: 9 August 2017

Prep: Cook: Serves:

The Big Lottery Fund has donated £60,000 to a Parkinson’s self-help group in Airdrie, Scotland.

The organisation will use the funds to support local residents who are living with Parkinson’s.

A Lottery spokesperson commented: “By offering a central meeting space and a programme of activities, the organisation will support people, families and carers to feel less isolated and encourage them to support each other, to better cope with the effects of the illness and the impact it has on their lives.”

A Parkinson’s self-help spokesperson said: “Among other things, these funds will help us secure staff salaries as well as costs for therapists.

“We will be working very closely with the Big Lottery Fund over the next year to help secure the group for years to come. We want to thank members for all of their support and hard work.”

Image credit: Tom Dick/Media Scotland

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Uncovered: 50-year-old footage of earliest Parkinson’s treatment

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Four women with Parkinson’s share their experience of lockdown

Take part in a survey to help improve DBS technology

The survey is available in four countries

Wearable device for Parkinson’s disease raises $10m in funding

UK-based tech company Charco Neurotech has secured $10 million in seed investment funding to support the launch of a non-invasive wearable device designed for people with Parkinson’s disease. CUE1 is a circular device worn on the sternum, which is designed to help alleviate Parkinson’s symptoms through specialised vibrations that are personalised for each patient. The investment round, which was co-led by venture capital company Amadeus Capital Partners and growth fund managers Parkwalk Advisors, is the largest European seed financing in 2021 for a heath technology device – and the sixth largest globally. Lucy Jung, co-founder and CEO of Charco Neurotech, said: “This funding will enable us to proceed with our first, limited launch, while we work to ensure our manufacturing line is robust and produces consistent high quality devices.” Charco also recently announced a new partnership with the European Parkinson’s Disease Association (EPDA), to help increase the availability of Charco’s…

Does Parkinson’s disease start in the nose?

An international team led by the University of Ottawa in Canada will study whether the scent-processing nerves inside the nose may play a part in the development of Parkinson’s disease. The researchers will explore potential connections between inflammation, environmental exposures in the nasal cavity, odour processing centres in the brain and Parkinson’s-related genes. The scientists hope that if the study indicates that Parkinson’s starts in the nose, early signs of the condition could potentially be detected sooner. This research, which will use human and animal models, has been made possible by a US $9m grant from the Aligning Science Across Parkinson’s (ASAP) initiative, which aims to improve understanding of the causes of the condition. “This grant will allow us to explore an understudied but important aspect of Parkinson’s, which could lead to new approaches for early treatment and prevention,” said Professor Michael Schlossmacher, team leader of the study.

Study finds gene therapy may restore effects of Parkinson’s drug

Levodopa is a drug commonly used to treat Parkinson’s as it helps to increase dopamine levels in the brain and improve problems with movement. In later stages of the condition, however, this treatment can become less effective. Now, findings from a US preclinical study have suggested that a new gene therapy may help to restore the effects of levodopa in people with the condition. The researchers used mice models of Parkinson’s to test the effects of the gene therapy, targeting a small region in the brain where dopamine-releasing neurons are present. They found that the therapy increased the neurons’ ability to convert levodopa to dopamine – and discovered that damage to the mitochondria in dopamine-releasing neurons may be enough to trigger Parkinson’s onset. The scientists hope their findings will encourage the development of therapies to preserve the function of these neurons, and support patients in the later stages of Parkinson’s.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Scottish Parkinson’s support group awarded £60,000 from Big Lottery Fund

News

Author: Parkinson's Life editorsPublished: 9 August 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Women and Parkinson's

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Europe

Take part in a survey to help improve DBS technology

Wearable device for Parkinson’s disease raises $10m in funding

Does Parkinson’s disease start in the nose?

Study finds gene therapy may restore effects of Parkinson’s drug

{title}

Subscribe

Scottish Parkinson’s support group awarded £60,000 from Big Lottery Fund

News

Author: Parkinson's Life editorsPublished: 9 August 2017

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Women and Parkinson's

“Life isn’t easy”: how coronavirus is affecting women with Parkinson’s

Europe

Take part in a survey to help improve DBS technology

Wearable device for Parkinson’s disease raises $10m in funding

Does Parkinson’s disease start in the nose?

Study finds gene therapy may restore effects of Parkinson’s drug

{title}

Subscribe

Sign in